Related Experiment Video
Updated: May 10, 2026

Models of Bone Metastasis
Published on: September 4, 2012
[Molecular biology of bone metastases]
Andreas Doll1, Marta García, Marina Rigau
1Programa de Investigación Traslacional en Cáncer de Próstata Vall d'Hebrón, Hospital Vall d'Hebrón. Barcelona, España. andreas.doll@vhir.org
Abstract:
Bone metastases are a frequent and devastating complication in cancer patients. Recently, significant advances in our understanding of the molecular mechanisms responsible for both osteolytic and osteoblastic bone metastases have occurred. The use of OMICS and the availability of appropriate preclinical animal models of bone metastasis have permitted the identification of factors produced by the tumor or by the host stroma in response to the tumor. These types of studies should result in a decrease of the serious skeletal morbidities associated with metastatic prostate cancer and may in the future improve overall survival. In this review the next generation of molecular targets in bone metastasis will be summarized.
Insights
Advances in understanding bone metastasis, using OMICS and animal models, identify new molecular targets. This research aims to reduce skeletal complications and improve survival in metastatic cancer patients.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Metastasis Research
Context:
- Bone metastases are a common and severe complication in cancer patients.
- Recent progress has elucidated molecular mechanisms driving osteolytic and osteoblastic bone metastases.
Purpose:
- To review recent advances in understanding the molecular mechanisms of bone metastasis.
- To summarize the next generation of molecular targets for treating bone metastases.
Summary:
- Utilizes OMICS technologies and preclinical animal models to identify key factors involved in bone metastasis.
- Highlights factors produced by tumors or host stroma that influence bone metastasis progression.
Impact:
- Aims to decrease skeletal morbidities associated with metastatic cancer, particularly prostate cancer.
- Potential to improve overall survival rates for patients with bone metastases.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Bone Remodeling
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Bone Structure

